<p>The present invention relates to growth hormone (GH) compounds having additional disulphide bridges and at least one additional single point mutation making the compounds resistant to proteolytic degradation.</p>
申请公布号
AU2011208620(A1)
申请公布日期
2012.07.19
申请号
AU20110208620
申请日期
2011.01.24
申请人
NOVO NORDISK HEALTH CARE AG
发明人
DEMUTH, HELLE;SCHIODT, CHRISTINE BRUUN SCHIODT;NORSKOV-LAURITSEN, LEIF;CHEN, JIANHE;THYGESEN, PETER
